Should I Take Daily Low-Dose Aspirin for APS Antibodies?
At a Glance
Daily low-dose aspirin is not automatically needed after a positive antiphospholipid antibody test. It may be considered for asymptomatic carriers with a high-risk antibody profile, but the decision should balance clot risk, bleeding risk, other medicines, and pregnancy plans with a clinician.
In this answer
4 sections
If you have tested positive for antiphospholipid (aPL) antibodies but have never had a blood clot, you are considered an “asymptomatic carrier.” Having the antibodies is not the same as having Antiphospholipid Syndrome (APS) — a diagnosis of APS requires both persistent antibodies and a qualifying clinical event, like a blood clot or specific severe pregnancy complications [1].
You might wonder if you should take daily low-dose aspirin (usually 75–100 mg) to prevent a first clot, a strategy known as primary prevention. The short answer is that major medical guidelines, such as those from the European Alliance of Associations for Rheumatology (EULAR), recommend considering low-dose aspirin if you have a high-risk antibody profile [2]. However, it is not an automatic requirement for everyone who tests positive [2].
The evidence showing that aspirin prevents a first clot in asymptomatic carriers is mixed, and taking it does not guarantee a clot will never happen [3][4]. Deciding whether to start requires an individualized discussion with your doctor to balance your specific risk of a clot against the risk of bleeding caused by aspirin [5].
Understanding Your Antibody Profile
Your doctor will look at three specific blood tests to determine your risk profile:
- Lupus anticoagulant (LA) (Note: testing positive for this does not mean you have the disease lupus)
- Anticardiolipin (aCL) antibodies
- Anti-beta-2-glycoprotein I (anti-β2GPI) antibodies
A high-risk profile generally means you have lupus anticoagulant, test positive for two or three of these antibodies at the same time (double or triple positivity), or have persistently high levels (titers) of the antibodies [2][6]. Because these tests can be temporarily positive due to a passing infection, persistence must be confirmed by retesting you at least 12 weeks after your first positive result [1][7].
If you have a confirmed high-risk profile, guidelines suggest low-dose aspirin may help reduce your risk of a first clot [2]. Conversely, if you have a single antibody at a low level that comes and goes, your baseline clot risk is likely much lower. In those cases, the bleeding risks of lifelong daily aspirin may outweigh the benefits [5][2].
Your doctor will also weigh other factors that increase your baseline clot risk, such as:
- Medical conditions: Having systemic lupus erythematosus (SLE), high blood pressure, high cholesterol, or obesity [2][6].
- Lifestyle and History: Smoking, or having a family history of APS or clotting disorders.
- Situational risks: Long flights, prolonged bed rest, hospitalization, or taking estrogen-containing birth control or hormone replacement therapy.
Weighing the Bleeding Risks
Aspirin is an antiplatelet medication—it makes your blood cells (platelets) less sticky. While this helps prevent clots, it also makes you bleed more easily [8]. Before starting, you and your doctor must review your personal bleeding risks:
- Gastrointestinal (GI) Bleeding: Aspirin increases the risk of bleeding in the stomach or intestines [9][10]. Inform your doctor if you have a history of stomach ulcers [11].
- Other Medications: Combining aspirin with NSAIDs (nonsteroidal anti-inflammatory drugs like ibuprofen or naproxen), prescription anticoagulants (blood thinners), or corticosteroids significantly increases your bleeding risk [11][12]. Always check with a pharmacist before taking over-the-counter pain relievers.
- Surgery and Dental Work: Never stop taking your aspirin on your own before a procedure. Many minor dental procedures do not require stopping. For major surgeries, which inherently increase your risk of a clot due to immobility, your surgeon and the doctor managing your antibodies must coordinate a specific plan [13][14].
- Menstrual Bleeding: Any medication that affects clotting can potentially make heavy menstrual periods worse. Report any new or markedly heavier bleeding to your doctor.
- Other Factors: Older age, uncontrolled high blood pressure, kidney disease, or a low platelet count (thrombocytopenia) also increase bleeding risk [15].
Pregnancy and Family Planning
If you are an asymptomatic carrier planning a pregnancy, consult an obstetrician or a maternal-fetal medicine (high-risk pregnancy) specialist before conceiving. Recommendations vary based on your exact history:
- Asymptomatic Carriers: For women with aPL antibodies but no history of clots or APS-related pregnancy complications, guidelines generally suggest low-dose aspirin alone during pregnancy [16][2].
- Obstetric APS: If you have a history of specific pregnancy complications (such as recurrent early miscarriages, late fetal loss, or premature delivery due to severe preeclampsia), this is classified as obstetric APS. Standard treatment for obstetric APS involves both low-dose aspirin and a prophylactic (preventive) dose of an injectable anticoagulant called heparin [2][1]. Aspirin alone is not enough if you have already been diagnosed with obstetric APS [2].
- Postpartum Care: The period immediately after giving birth is a very high-risk time for blood clots. Your care team will create a postpartum plan, which often involves six weeks of preventive heparin.
🚨 Urgent Warning Signs
Do not start, stop, or change an aspirin regimen without your clinician’s guidance. Seek immediate emergency medical care if you experience:
- Signs of a Clot: Sudden shortness of breath, chest pain, coughing up blood, new swelling or pain in one leg, or sudden neurological symptoms (like weakness on one side of your body, drooping face, or slurred speech).
- Signs of Severe Bleeding: Black or tarry stools, vomiting blood or material that looks like coffee grounds, fainting, or any unusual, persistent bleeding that will not stop.
Not a Substitute for Clot Treatment
If you ever develop a blood clot, your diagnosis will change to thrombotic APS. Low-dose aspirin is for primary prevention; it is never a substitute for prescription anticoagulants (like warfarin or heparin) if you have already had a clot [17].
Common questions in this guide
Does a positive APS antibody test mean I have antiphospholipid syndrome?
Should everyone with antiphospholipid antibodies take daily low-dose aspirin?
What makes an APS antibody profile high risk?
Can aspirin increase bleeding if I have stomach problems or take other medicines?
What should I do about aspirin if I am planning a pregnancy?
Can low-dose aspirin replace anticoagulants after a blood clot?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my specific antibody test results (LA, aCL, anti-β2GPI), titers, and repeat testing, do I have a high-risk or low-risk profile?
- 2.Given my family history of familial antiphospholipid syndrome and my personal health, what is my estimated baseline risk for a blood clot?
- 3.Given my history of stomach issues or heavy menstrual bleeding, do the potential benefits of daily low-dose aspirin outweigh the bleeding risks for me?
- 4.How should we manage my clot risk during temporary high-risk periods like long flights, surgery, or hospitalization?
- 5.If I plan to become pregnant, when should I consult a maternal-fetal medicine specialist to adjust my medication plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Antiphospholipid syndrome.
Sammaritano LR
Best practice & research. Clinical rheumatology 2020; (34(1)):101463 doi:10.1016/j.berh.2019.101463.
PMID: 31866276 - 2
EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG, Andreoli L, Limper M, et al.
Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.
PMID: 31092409 - 3
Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis.
De Pascali F, Filippova YA, Donadini MP, et al.
Thrombosis research 2025; (245()):109225 doi:10.1016/j.thromres.2024.109225.
PMID: 39603009 - 4
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM, Paszek E, Lesniak W, et al.
The Cochrane database of systematic reviews 2018; (7()):CD012534 doi:10.1002/14651858.CD012534.pub2.
PMID: 30004572 - 5
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
Zuo Y, Barbhaiya M, Erkan D
Current rheumatology reports 2018; (20(11)):66 doi:10.1007/s11926-018-0775-8.
PMID: 30203272 - 6
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
Tektonidou MG
Journal of autoimmunity 2022; (128()):102813 doi:10.1016/j.jaut.2022.102813.
PMID: 35247655 - 7
Antiphospholipid syndrome: Diagnosis and management in the obstetric patient.
Arslan E, Branch DW
Best practice & research. Clinical obstetrics & gynaecology 2020; (64()):31-40 doi:10.1016/j.bpobgyn.2019.10.001.
PMID: 31704207 - 8
The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.
Patrono C
Journal of the American College of Cardiology 2015; (66(1)):74-85.
PMID: 26139061 - 9
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM, Evans CV, Perdue LA, et al.
JAMA 2022; (327(16)):1585-1597 doi:10.1001/jama.2022.3337.
PMID: 35471507 - 10
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.
Whitlock EP, Burda BU, Williams SB, et al.
Annals of internal medicine 2016; (164(12)):826-35 doi:10.7326/M15-2112.
PMID: 27064261 - 11
Genetic Variants in PTGS1 and NOS3 Genes Increase the Risk of Upper Gastrointestinal Bleeding: A Case-Control Study.
Forgerini M, Urbano G, de Nadai TR, et al.
Frontiers in pharmacology 2021; (12()):671835 doi:10.3389/fphar.2021.671835.
PMID: 34290607 - 12
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
García Rodríguez LA, Martín-Pérez M, Hennekens CH, et al.
PloS one 2016; (11(8)):e0160046 doi:10.1371/journal.pone.0160046.
PMID: 27490468 - 13
A Comprehensive Update on Aspirin Management During Noncardiac Surgery.
Gerstein NS, Albrechtsen CL, Mercado N, et al.
Anesthesia and analgesia 2020; (131(4)):1111-1123 doi:10.1213/ANE.0000000000005064.
PMID: 32925332 - 14
Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis.
Shah S, Urtecho M, Firwana M, et al.
Mayo Clinic proceedings. Innovations, quality & outcomes 2022; (6(6)):564-573 doi:10.1016/j.mayocpiqo.2022.09.006.
PMID: 36304523 - 15
Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis.
Huang WY, Saver JL, Wu YL, et al.
JAMA neurology 2019; (76(8)):906-914 doi:10.1001/jamaneurol.2019.1120.
PMID: 31081871 - 16
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
, Silver R, Craigo S, et al.
American journal of obstetrics and gynecology 2023; (228(3)):B41-B60 doi:10.1016/j.ajog.2022.09.001.
PMID: 36084704 - 17
Prevention of thrombosis in antiphospholipid syndrome.
Lim W
Hematology. American Society of Hematology. Education Program 2016; (2016(1)):707-713 doi:10.1182/asheducation-2016.1.707.
PMID: 27913550
This page is for informational purposes only and does not constitute medical advice. Do not start or stop aspirin without discussing your antibody results, clot risk, bleeding risk, and pregnancy plans with your clinician.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.